352 related articles for article (PubMed ID: 28281220)
1. The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.
Flynn NJ; Somasundaram R; Arnold KM; Sims-Mourtada J
Target Oncol; 2017 Apr; 12(2):139-152. PubMed ID: 28281220
[TBL] [Abstract][Full Text] [Related]
2. [Which future for B lymphocytes infiltrating solid tumors: prognostic biomarker and/or therapeutic target?].
Kaplon H; Dieu-Nosjean MC
Med Sci (Paris); 2018 Jan; 34(1):72-78. PubMed ID: 29384099
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.
Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN
Front Immunol; 2021; 12():731329. PubMed ID: 35069521
[TBL] [Abstract][Full Text] [Related]
4. Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity.
Qin Y; Lu F; Lyu K; Chang AE; Li Q
Front Immunol; 2022; 13():881427. PubMed ID: 35967441
[TBL] [Abstract][Full Text] [Related]
5. Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers.
Zhong Z; Nan K; Weng M; Yue Y; Zhou W; Wang Z; Chu Y; Liu R; Miao C
Front Immunol; 2021; 12():765044. PubMed ID: 34868013
[TBL] [Abstract][Full Text] [Related]
6. B cells and their mediators as targets for therapy in solid tumors.
Gunderson AJ; Coussens LM
Exp Cell Res; 2013 Jul; 319(11):1644-9. PubMed ID: 23499742
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of B Cells in Tumor Immunity.
Tsou P; Katayama H; Ostrin EJ; Hanash SM
Cancer Res; 2016 Oct; 76(19):5597-5601. PubMed ID: 27634765
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Associated Disialylated Glycosphingolipid Antigen-Revealing Antibodies Found in Melanoma Patients' Immunoglobulin Repertoire Suggest a Two-Direction Regulation Mechanism Between Immune B Cells and the Tumor.
Kotlan B; Horvath S; Eles K; Plotar VK; Naszados G; Czirbesz K; Blank M; Farkas E; Toth L; Tovari J; Szekacs A; Shoenfeld Y; Godeny M; Kasler M; Liszkay G
Front Immunol; 2019; 10():650. PubMed ID: 31024530
[TBL] [Abstract][Full Text] [Related]
9. The B-side of Cancer Immunity: The Underrated Tune.
Largeot A; Pagano G; Gonder S; Moussay E; Paggetti J
Cells; 2019 May; 8(5):. PubMed ID: 31086070
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Badalamenti G; Fanale D; Incorvaia L; Barraco N; Listì A; Maragliano R; Vincenzi B; Calò V; Iovanna JL; Bazan V; Russo A
Cell Immunol; 2019 Sep; 343():103753. PubMed ID: 29395859
[TBL] [Abstract][Full Text] [Related]
11. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
12. B cell regulation of anti-tumor immune response.
Zhang Y; Morgan R; Podack ER; Rosenblatt J
Immunol Res; 2013 Dec; 57(1-3):115-24. PubMed ID: 24293009
[TBL] [Abstract][Full Text] [Related]
13. B Cells as an Immune-Regulatory Signature in Ovarian Cancer.
Gupta P; Chen C; Chaluvally-Raghavan P; Pradeep S
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31248034
[TBL] [Abstract][Full Text] [Related]
14. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors.
Melaiu O; Lucarini V; Cifaldi L; Fruci D
Front Immunol; 2019; 10():3038. PubMed ID: 32038612
[TBL] [Abstract][Full Text] [Related]
15. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
Iglesia MD; Parker JS; Hoadley KA; Serody JS; Perou CM; Vincent BG
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27335052
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer.
Wang SS; Liu W; Ly D; Xu H; Qu L; Zhang L
Cell Mol Immunol; 2019 Jan; 16(1):6-18. PubMed ID: 29628498
[TBL] [Abstract][Full Text] [Related]
17. Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.
Sasada T; Suekane S
Immunotherapy; 2011 Oct; 3(10):1235-51. PubMed ID: 21995574
[TBL] [Abstract][Full Text] [Related]
18. Overcoming tumor-mediated immunosuppression.
Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
[TBL] [Abstract][Full Text] [Related]
19. A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity.
Liu M; Sun Q; Wang J; Wei F; Yang L; Ren X
Int J Cancer; 2019 Jun; 144(12):2909-2917. PubMed ID: 30183084
[TBL] [Abstract][Full Text] [Related]
20. Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors.
Jin C; Yu D; Essand M
Immunotherapy; 2016 Dec; 8(12):1355-1361. PubMed ID: 28000533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
